I agree that this site is using cookies. You can find further informations here.
X
Zabana, Y
70  results:
Search for persons X
?
1

P081 The integration of transcriptomic and microbiomic data..:

Cabrer, M ; Suau, R ; Lopez-Siles, M...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i355-i356 , 2024
Link: https://doi.org/10.1093/..
 
?
2

DOP79 Promising efficacy of biologicals and small molecules..:

Verstockt ., B ; Taelman, T ; Vavricka, S R...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i219-i221 , 2024
Link: https://doi.org/10.1093/..
 
?
3

P493 Do antiTNF or Ustekinumab trough levels correlate with..:

Madero Velázquez, L ; Zapater, P ; Mira, C...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i984-i985 , 2024
Link: https://doi.org/10.1093/..
 
?
4

P989 Switching from intravenous to subcutaneous vedolizumab..:

Gros, B ; Manceñido Marcos, N ; Guardiola, J...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1793-i1795 , 2024
Link: https://doi.org/10.1093/..
 
?
5

P817 Incidence and risk factors of infection in patients wi..:

Zabana, Y ; Rodríguez-Lago, I ; Sicilia, B...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1518-i1520 , 2024
Link: https://doi.org/10.1093/..
 
?
6

P168 Specialized pro-resolving lipid mediator Resolvin D1 a..:

Suau, R ; Pardina, E ; Clua, L...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i473-i474 , 2024
Link: https://doi.org/10.1093/..
 
?
7

OP37 Effect of the HLA-DQA1*05 allele on the efficacy of us..:

Guardiola Capón, J ; Iborra, M ; Padró, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i67-i67 , 2024
Link: https://doi.org/10.1093/..
 
?
8

P829 Clostridioides difficile infection in patients using v..:

Gonzalez Vivo, M ; Font Ordeig, G ; López Romero-Salazar, F...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1545-i1546 , 2024
Link: https://doi.org/10.1093/..
 
?
9

P524 Etrasimod shows low risk of adverse events following c..:

Afzali, A ; Regueiro, M ; Yarur, A J...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1033-i1034 , 2024
Link: https://doi.org/10.1093/..
 
?
10

P1115 Characteristics and management of pyoderma gangrenosu..:

Rodríguez-Lago, I ; Vela, M ; Ordás, I...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i2000-i2001 , 2024
Link: https://doi.org/10.1093/..
 
?
11

DOP17 HIV infection is associated with a less aggressive ph..:

Calafat Sard, M ; Súria, C ; Mesonero, F...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i80-i81 , 2023
Link: https://doi.org/10.1093/..
 
?
12

OP26 Impact of telemonitoring on the management of Inflamma..:

Aguas Peris, M ; Del Hoyo, J ; Vicente, R...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i35-i37 , 2023
Link: https://doi.org/10.1093/..
 
?
13

P625 Randomized controlled trial on the effect of megabolus..:

Llaó, J ; Martín-Arranz, E ; Zabana, Y...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i755-i756 , 2023
Link: https://doi.org/10.1093/..
 
?
14

P023 Immune-metabolic profiles of creeping fat in relation ..:

Suau, R ; Pardina, E ; López-Tejero, M D...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i192-i194 , 2023
Link: https://doi.org/10.1093/..
 
?
15

P424 Do antiTNF through levels correlate with joint extrain..:

Madero Velázquez, L ; Jovani, V ; Andrés, M...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i553-i554 , 2023
Link: https://doi.org/10.1093/..
 
1-15